Hematology CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
Integrating BTK Inhibitors Into the Management of B-Cell Malignancies: How Is Evidence Driving Patient Care?
12 October, 2018
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
9 October, 2018

Pages